Evidence map›Paper›PMID 37745747›Full record

ArticleCureus2023

Complementary and Alternative Medicine Use Among Patients With Diabetes Mellitus in Saudi Arabia: A Community-Based Cross-Sectional Study.

Khaled A Yaghmour, Raneem Abu Sadi, Ftoon Badroun, Rezan Alali, Fatimah Almubarak, Zainab Alabbad, Noura Alharthi, Jamil A Samkari, Mahmoud A Gaddoury

Abstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Khaled A YaghmourFamily Medicine Department, King Abdulaziz University, Jeddah, SAU.
Raneem Abu SadiMedical Intern, King Abdulaziz University Faculty of Medicine, Jeddah, SAU.
Ftoon BadrounMedical Intern, King Abdulaziz University, Jeddah, SAU.
Rezan AlaliMedical Intern, King Abdulaziz University Faculty of Medicine, Jeddah, SAU.
Fatimah AlmubarakMedical Intern, King Abdulaziz University Faculty of Medicine, Jeddah, SAU.
Zainab AlabbadMedical Intern, King Abdulaziz University Faculty of Medicine, Jeddah, SAU.
Noura AlharthiMedical Intern, King Abdulaziz University Faculty of Medicine, Jeddah, SAU.
Jamil A SamkariFamily and Community Medicine, King Abdulaziz University Faculty of Medicine, Rabigh, Jeddah, SAU.
Mahmoud A GaddouryCommunity Medicine, King Abdulaziz University, Faculty of Medicine, Jeddah, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlobal studies have observed a disparity in the use of complementary and alternative medicine (CAM) among diabetic patients.

objectivesTo estimate the prevalence, types, and correlates of CAM use among patients with diabetes mellitus (DM) in Saudi Arabia. METHODOLOGY: A cross-sectional study was conducted among 1290 Saudis with type 2 DM aged ≥18 years. An electronic questionnaire was distributed through social media to collect data about patient demographics and DM-related characteristics, including age at DM diagnosis, DM duration, family history of DM, DM complications, DM medicine, and chronic diseases. The use of CAM and its type, cost, and duration; sources of CAM-related information; reason for using CAM; usefulness and side effects; CAM use in the future; and doctor consultation before CAM use were also evaluated. Among CAM non-users, the reason for not using CAM and future considerations of CAM were assessed.

resultsA total of 1290 patients were included (27.4%) aged 18-29 years; 726 (56.3%) were women; 554 (42.9%) had a bachelor's degree in education; and 457 (35.4%) were unemployed. The prevalence of CAM use was 528 (40.9%). The most commonly used types were bitter apple 503 (95.3%), cinnamon 341 (64.6%), and ginger 290 (55.1%). The most frequent sources of CAM-related information were friends, families, and neighbors 259 (49.2%), while the most frequent justifications for use were the need for another DM treatment and faith in its advantages. Only 106 (20.1%) of the patients who used CAM disclosed adverse effects; 373 (51.8%) said they would use it again, and 66.1% said they would recommend it to other patients. Only 145 (27.5%) consulted a doctor before using CAM. CAM was more commonly used by patients who were older, women, married, and taking hypoglycemic drugs; whose most recent HbA1c level was 7-10%; and who had dyslipidemia, chronic disease, and a family history of DM.

conclusionThe prevalence of CAM use is high among the Saudi population. Analyzing CAM use is essential in clinical interactions with Saudis with DM. The managing healthcare professionals must educate patients with DM on how to use CAM more effectively and safely.

Indexed as

community-basedcomplementary and alternativecross-sectionaldiabetes mellituspatientssaudi

Identifiers

PMID37745747
PMCPMC10517425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.